Table 3 Objective response rate by crizotinib treatment
Response | No. of Patients (%) | P-value | |
|---|---|---|---|
ALK + c-Met- (n = 101) | ALK + c-Met+ (n = 15) | ||
Complete response, n (%) | 0(0.0%) | 0(0.0%) | Â |
Partial response, n (%) | 60(59.4%) | 13(86.7%) | Â |
Stable disease, n (%) | 25(24.8%) | 2(13.3%) | Â |
Progressive disease, n (%) | 16(15.8%) | 0(0.0%) | Â |
ORR, % | 59.4% | 86.7% | 0.041 |
DCR, % | 84.2% | 100% | 0.126 |